GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

The Global Enteral Feeding Formulas Market size is expected to reach US$ 10.94 Bn by 2030, from US$ 5.79 Bn in 2023, exhibiting a CAGR of 9.5% during the forecast period.

Enteral feeding formulas serve as nutritional supplements delivered directly into the stomach, duodenum, or jejunum for individuals unable to attain sufficient oral intake.

Global Enteral Feeding Formulas Market - Regional Insights

• North America is expected to be the largest market for enteral feeding formulas during the forecast period, accounting for over 38.7% of the market share in 2023. As of 2021, North America, encompassing the U.S. and Canada, dominated the enteral feeding formulas market, holding the largest market share. The enteral feeding formulas sector is firmly established in North America, with its growth driven by several factors. The rising incidence of chronic diseases in the region, the abundance of well-equipped hospitals, and a gradual transition from parenteral to enteral nutrition contribute to the robust expansion of this market. Moreover, the presence of a developed healthcare infrastructure and favorable reimbursement policies have propelled the market growth. Hospitals and long-term care facilities in the U.S. and Canada readily adopt new enteral nutrition products, which also ensures a steady demand. As of 2022, the Rural Health Information Hub reports that the U.S. has a population of over 46 million individuals aged 65 or older. Projections suggest that by the year 2050, this figure is expected to nearly double, reaching close to 90 million older adults. The increasing prevalence of the geriatric population is anticipated to be a key driver for the growth of the enteral feeding formulas market in the U.S. The adoption of enteral feeding formulas is expected to rise within this age group, reflecting a broader trend in healthcare and nutrition.
• Asia Pacific is expected to be the second-largest market for enteral feeding formulas, accounting for over 23.2% of the market share in 2023. The Asia Pacific region has positioned itself as the most rapidly expanding market for enteral feeding formulas, with countries like China and India anticipated to make substantial contributions to this regional growth. Several factors contribute to this surge, including the increasing prevalence of chronic diseases and disorders, a growing geriatric population, rising healthcare expenditures, and the availability of low-cost products. As a result, the demand for enteral feeding formulas in the Asia Pacific region is on the rise.

In certain Asian nations, the absence of well-established reimbursement structures has led to the promotion of cost-effective enteral nutrition therapy. Local manufacturers are seizing the opportunity by expanding their presence and offering comparable products at competitive prices. This strategy enhances the accessibility of enteral feeding formulas for patients in these regions. Furthermore, the economic development across Asia Pacific has resulted in improved infrastructure and elevated health standards, facilitating early disease detection and management. The overall enhancement of healthcare indices across the region is contributing to the growth of the enteral feeding formulas market in Asia Pacific. With substantial production capabilities and a large population base, Asia Pacific is poised to become a significant manufacturing and consumption hub for enteral feeding formulas in the years to come.

The enteral feeding formulas market in Europe is influenced by an aging population, robust healthcare infrastructure, and regulatory standards. Demographic shifts, competition among healthcare companies, and technological advancements shape this market with a share of 20.2% during the forecast period. Ongoing research and consumer awareness contribute to the dynamic landscape. For the latest insights, consulting recent reports and industry updates are recommended.

Analyst’s Views: Anticipated to exhibit consistent growth, the enteral feeding formulas market will be propelled by the increasing incidence of chronic diseases causing malnutrition. The widespread adoption of tube feeding as a viable nutritional support method will contribute to market expansion. The primary consumer base comprises the growing geriatric population prone to age-related ailments. However, potential constraints include the elevated costs of specialized formulas and potential complications linked to tube feeding. Yet, advancements introducing disease-specific formulas targeting gut health, immunity, or organ function have the potential to enhance patient outcomes, fostering the market growth.

Figure 1. Global Enteral Feeding Formulas Market Share (%), By Region, 2023

To learn more about this report, request a free sample copy

Global Enteral Feeding Formulas Market- Drivers

• Rising incidence of chronic diseases: The rising prevalence of chronic diseases across global populations is a major factor driving growth in the enteral feeding formulas market. Chronic conditions, such as cancer, gastrointestinal disorders, neurological disorders, and others, that hamper natural oral consumption of food are increasingly common. For instance, as per the World Health Organization, the chronic disease burden is expected to reach 57% of the total global disease burden by 2020. Similarly, the National Cancer Institute estimates that the number of cancer patients worldwide will rise to 27.5 million by 2040 from 19.3 million in 2020. Conditions resulting from chronic diseases often lead to impaired swallowing function, bowel obstruction, or malabsorption issues. In such cases, enteral nutrition through feeding tubes provides nutritional support to help patients meet their daily requirements in an easy-to-digest, pre-packaged form. This helps avoid complications of malnutrition and supports faster recovery. The ability of enteral formulas to fulfill nutritional needs with minimum effort makes them a preferred option among healthcare providers and patients. With projections of continued rise in chronic ailments, the demand for customized enteral formulas tailored for individual health conditions and lifestyle needs is growing. Furthermore, advancements in formulation technology are also contributing to the market potential. New formulas enriched with probiotics, prebiotics, or pharma nutrients allow addressing multiple health targets through a single solution. This has boosted uptake across settings from critical care to long-term care. Upcoming areas dominated by geriatric population growth also present major opportunities. With chronic diseases affecting quality of life more than ever before, enteral feeding formulas are increasingly becoming a principle part of treatment pathways. The future outlook remains positive as formulation innovations and demographic shifts maintain high dependence on nutritional support through tube feeding.
• Changes in healthcare landscape and reimbursement policies: Changes in the healthcare landscape along with evolving reimbursement policies are major factors driving the growth of the enteral feeding formulas market. Traditionally, tube feeding was mainly administered in hospitals for short-term illnesses or recoveries. However, with the focus shifting towards home healthcare and reducing hospital readmissions, there has been a rise in long-term home enteral nutrition over the past decade. This trend is encouraging patients requiring long-term enteral nutrition to shift from hospitals to homecare setting. Home enteral feeding offers several advantages like improved quality of life, reduced healthcare costs, and risk of hospital acquired infections. It allows patients to receive specialized nutrition in a more convenient and comfortable environment. This shift towards home healthcare is increasing the demand for easy to administer and portable enteral feeding products like tube feeding formula in liquid or powder form and portable pumps.
• Increasing preference for homecare services: With increase in chronic illness and preference for homecare, the demand for enteral feeding formulas has increased significantly. More patients are now preferring homecare over institutional care as it provides comfort of staying with family and flexible administration of nutrition. Chronic conditions like cancer and gastrointestinal disorders often require artificial feeding support through enteral tubes. Home enteral nutrition helps in improving the quality of life for millions of people with swallowing difficulties or inability to eat independently. Families also find it economically viable compared to hospital stays. Many government programs are promoting home healthcare as it reduces burden on limited hospital resources. As per data from the World Health Organization, chronic diseases accounted for 71% of global deaths in 2019. These long term conditions require long term nutritional support. With growing geriatric population globally, the incidence of chronic illness is projected to rise substantially in the coming years. As per United Nations population projections, the number of people aged 60 years or over is estimated to more than double, from 900 million globally in 2015 to about 2.10 billion in 2050. The rise in aging population will further propel the demand for home enteral tube feeding products.

Global Enteral Feeding Formulas Market- Opportunities

• Emerging markets in developing countries: Emerging markets in developing countries present a great opportunity for growth in the enteral feeding formulas market. As economies in regions like Southeast Asia, South Asia, Latin America, and Africa continue to develop and incomes rise, more people will have access to medical treatment and nutrition support. This increasing demand for quality healthcare will directly boost the enteral feeding formulas market.
• Many developing nations are experiencing rapid urbanization as their populations shift from rural to urban areas. This massive demographic transition brings both opportunities and challenges for public health. Non-communicable diseases linked to changing lifestyles are on the rise. At the same time, access to medical facilities is improving in cities but remains limited in many parts. As a result, more people may require enteral feeding formulas to manage health conditions or receive adequate nutrition, especially in underserved communities.
• Growing demand for organic and natural enteral formulas: The growing demand for organic and natural enteral formulas presents a major opportunity in the enteral feeding formulas market. In recent years, there has been a strong shift in consumer preference towards organic and natural products due to rising health consciousness. As people are becoming more aware of the synthetic ingredients and chemicals present in traditional formulas, they are looking for cleaner options that are free from artificial colors, flavors and preservatives.
• This change in consumer attitude has led to double digit growth of the organic baby food category over the past five years according to data from the Organic Trade Association. As more scientific research emerges on the link between gut health and overall wellness, parents are increasingly interested in feeding their children formulas made from natural, easy to digest ingredients. Similarly, adult consumers requiring enteral nutrition are also gravitating towards minimally processed options. The growing emphasis on sustainability is also driving demand for formulas packaged in plant-based or recyclable materials rather than plastic.

Global Enteral Feeding Formulas Market- Trends

• Customized formulae for specific clinical conditions: The demand for customized enteral feeding formulas tailored to specific clinical conditions is gaining significant traction in the market. With advancements in medical research, customized formulas are being formulated to address the unique nutritional needs of patients with complex diagnoses. This trend allows for a more tailored nutritional therapy compared to generic formulas. As per the National Health and Nutrition Examination Survey conducted by the CDC between 2015 and 2020, approximately 13% of American adults suffer from conditions requiring specialized enteral nutrition such as diabetes, cancer, renal disease, and chronic lung disorders.
• Rise in the demand for disease-specific enteral nutrition: Disease-specific enteral formulas allow for individually tailored macronutrient and micronutrient content to optimize clinical outcomes for patients. For example, diabetes-specific formulas contain regulated carbohydrate levels and fiber to help manage blood sugar. Formulas for cancer and gastrointestinal diseases focus on easing symptoms like diarrhea, maintaining weight, and muscle mass during treatment. The added health benefits of tailored nutrition are boosting compliance and willingness to pay premium prices compared to general formulas.

Global Enteral Feeding Formulas Market - Restraints

• Risk of infection associated with tubes: The risk of infection associated with feeding tubes is one of the major factors restraining the growth of the enteral feeding formulas market. Tube feeding involves placing a feeding tube directly into the stomach, duodenum, or jejunum, either through the nose or directly into the stomach through the abdominal wall. This invasive method of feeding predisposes the patients to various health risks. The feeding tubes are also prone to contamination if not handled properly. According to a report by the World Health Organization in 2022, contamination of feeding tubes is one of the major causes of healthcare-associated infections globally. Improper cleaning and disinfection of feeding tubes can lead to transmission of pathogens. This risk is higher in developing countries where resources for infection control practices might be limited. The report estimated that in low-income countries, up to 15% of hospitalized patients acquire at least one healthcare-associated infection as a result of contaminated medical equipment including feeding tubes.
• Availability of alternative nutrition therapies: The availability of alternative nutrition therapies is posing a significant challenge for the growth of enteral feeding formulas market. In recent years, there is a rising popularity of therapeutic diets, herbal supplements, and naturopathic remedies for managing various health conditions. Many people are adopting these alternative options to get a personalized and natural treatment instead of relying solely on medical nutrition therapy using commercial formulas. While enteral tube feeding still remains indispensable for several clinical conditions, the growing access to safer and more personalized alternative nutrition therapies is presenting a significant challenge for manufactures to incentivize long-term formula use. This restrains the potential growth trajectory of the enteral feeding formulas market.

Figure 2. Global Enteral Feeding Formulas Market Share (%), By Product, 2023

To learn more about this report, request a free sample copy

Global Enteral Feeding Formulas Market- Recent Developments

Business Development Activities by the Market Players

• On September 28, 2023, Cardinal Health, a U.S.-based multinational health care services company, announced the Kangaroo OMNI Enteral Feeding Pump in the US. This innovative pump is designed to offer more options for enteral feeding patients, catering to their personalized needs throughout the enteral feeding journey. This launch signifies Cardinal Health's commitment to enhancing the options available for patients undergoing enteral feeding, providing a more tailored and flexible approach to their medical care.
• On September 18, 2023, Vonco Products LLC, a prominent risk-free plastic and packaging manufacturer, reported that the U.S. Food and Drug Administration (FDA) has granted clearance for EnteraLoc Flow as an over-the-counter (OTC) direct-connect feeding solution for enteral patients. This regulatory approval reflects a significant milestone for Vonco Products, enabling broader accessibility to EnteraLoc Flow and enhancing options for enteral patients seeking feeding solutions.
• In May 2022, Abbott, a U.S.-based multinational medical devices and health care company, announced that the U.S. District Court for the Western District of Michigan has modified the recent consent decree, enabling the release of restricted quantities of its EleCare specialty amino acid-based formulas. This decision follows the recall of certain powder infant formulas from Abbott's Sturgis, Michigan, U.S., facility on February 17, 2022. The amendment allows for the distribution of EleCare products that were temporarily withheld, addressing concerns related to the recal

Top Companies in the Global Enteral Feeding Formulas Market

• Nestle
• VICTUS
• Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co., Ltd.
• Mead Johnson & Company, LLC
• Abbott
• Danone S.A
• Fresenius Kabi AG

Definition: Enteral feeding formulas, also known as enteral nutrition or tube feeding formulas, are specialized liquid nutritional products designed for individuals who are unable to consume food orally or have difficulty in swallowing. These formulas provide essential nutrients such as proteins, carbohydrates, fats, vitamins, and minerals to meet the nutritional needs of the body. Enteral feeding is administered through a feeding tube that can be inserted into the stomach, duodenum, or jejunum, depending on the patient's condition and medical requirements. There are various types of enteral feeding formulas, and they can be categorized based on their composition and intended use.